Navigation Links
Prescient Medical, Inc. CEO Patricia Scheller to Speak at 'The Value of Innovation in Health Care,' a Galen Institute Conference
Date:12/7/2009

DOYLESTOWN, Pa., Dec. 7 /PRNewswire/ -- Patricia Scheller, CEO of Prescient Medical, Inc., will be among the speakers at the Galen Institute's "The Value of Innovation in Health Care" conference. The conference will take place on Wednesday, December 9th in Washington DC at the Columbus Club at Union Station.

The Galen Institute is a non-profit public policy research organization focusing on health and tax policy.

"I'm very pleased to be part of the Galen Institute's conference," said Ms. Scheller. "As the debate on health care reform continues, there appears to be bipartisan agreement that continued innovation in medical research and the development of pioneering medical technology is critical. The US has historically led the world in advancing medical progress and the policy initiatives being discussed have the potential to profoundly impact our future position. The Galen Institute's conference offers a wonderful opportunity to provide input to lawmakers on how their policies can promote innovation."

The event unites policy experts, elected officials, and leaders in a number of health care-related industries to discuss the effects of health care reform on innovation. Prescient Medical has developed two breakthrough interventional cardiology solutions: the vProtect(TM) Luminal Shield and the vPredict(TM) Optical Catheter System.

The vProtect(TM) Luminal Shield is a novel self-expanding coronary stent-like Shield that received CE Mark certification in August, 2009, allowing it to be marketed in Europe for improving coronary artery luminal diameter in patients with symptomatic ischemic heart disease. The Shield was recently honored with Frost & Sullivan's 2009 North American Product Innovation of the Year Award. Designed specifically to minimize arterial injury and its consequences, the Shield is ideal for treating softer plaques, such as those that are typically associated with heart attacks.

The vPredict(TM) Optical Catheter System is being developed for the detection and characterization of soft plaque. Its technology platform is based on Raman spectroscopy, a highly sensitive technique proven in numerous non-clinical applications. The vPredict(TM) System detects clinically important compounds, including cholesterols, in the vessel wall and plaque. The goal of the vPredict(TM) System is to provide physicians with information to identify patients at risk for a heart attack and treat them proactively.

For more information on Prescient Medical or its products, please contact Ilana Odess, General Manager of Prescient Medical, at: iodess@pmivp.com.

About Prescient Medical, Inc.

Prescient Medical, Inc. is a privately held medical device company dedicated to reducing deaths from heart attacks, the leading cause of death in much of the world. The company is the recipient of the 2009 Frost and Sullivan Award for Product Innovation of the Year Award for vProtect(TM) Luminal Shield. For more information about Prescient Medical and its products, please visit www.prescientmedical.com.

SOURCE Prescient Medical, Inc.


'/>"/>
SOURCE Prescient Medical, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Prescient Medical vProtect(TM) Luminal Shield Receives North American Product Innovation of the Year Award from Frost & Sullivan
2. Prescient Medical Inc. Featured on FOX Business Network
3. vProtect Luminal Shield (TM) from Prescient Medical Receives CE Mark
4. Prescient Medical Receives Frost & Sullivan Product Innovation of the Year Award
5. Momentum Women(TM) Honors Patricia Scheller of Prescient Medical for Commitment to Promoting Cardiovascular Disease Awareness
6. Nationwide Imaging Services, Inc., Leader In Diagnostic Imaging Equipment, Announces Acquisition Of Kosmic Medical, Inc. (dba Atlas Medical Technologies of California)
7. Amalgamated Capital Serves as Syndication Agent in the Recapitalization of 180 Medical, Inc.
8. Entest BioMedical, Inc. Discusses How Therapies in Development May Yield Lucrative Revenue Streams for the Company
9. Solta Medical, Inc. Appoints Jeffrey Nardoci Vice President of Global Marketing
10. Trapeze Networks Announces Trapeze Medical, Bringing Medical-Grade Mobility to Healthcare Market
11. China Sky One Medical, Inc. Exports Pain Relief Patch to Canada
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/18/2017)... , ... January 18, 2017 , ... At Hallmark Nameplate, ... announce that they have achieved certification to ISO 13485. This certification is another way ... up to date products and services that they need. , The ISO 13485 Certification ...
(Date:1/18/2017)... NH (PRWEB) , ... January 18, 2017 , ... ... launch of the revolutionary Active Brake Technology (ABT), an innovative braking system that ... , Active Brake Technology addresses one of the biggest concerns of beginner and ...
(Date:1/17/2017)... NY (PRWEB) , ... January 17, 2017 , ... Gym ... opening of a new showroom at South Dixie Hwy in Miami, FL. , “We ... at Gym Source. “The new innovative in-store concept is designed to give clients a ...
(Date:1/17/2017)... ... ... SunView Software’s Service Smart Technology has been selected as a finalist for Pink ... Pink Elephant recognizes a new product or service developed by an IT services vendor ... The award highlights original innovations that were released in 2016, either as a major ...
(Date:1/17/2017)... ... 2017 , ... Mirror Mirror Beauty Boutique, Houston’s premiere CoolSculpting provider , ... Zeltiq’s Crystal Rewards Program. Practice founder, Paul Vitenas, MD FACS, is delighted that Mirror ... , Produced by Zeltiq, CoolSculpting is approved by the Food and Drug Administration as ...
Breaking Medicine News(10 mins):
(Date:1/18/2017)... In China , we say Health is ... China,s Healthy Strategy originates. 2016 is ... and Social Development of the People,s Republic of ... council of the People,s Republic of China ... plan, identifying medical devices as one of the main breakthrough ...
(Date:1/18/2017)... SAN DIEGO , Jan. 18, 2017 /PRNewswire/ ... manufacturing solutions for cell and advanced therapies , ... the French biopharmaceutical company developing "tumor starvation" treatments ... unmet medical needs. Under the agreement, Invetech will ... products based on Erytech,s proprietary ERYCAPS technology platform, ...
(Date:1/18/2017)... 18, 2017  Tarix Orphan LLC today announced that ... Rare Pediatric Disease (RPD) designation for the company,s drug ... Bullosa (RDEB), a rare genetic skin disorder. There are ... limited to supportive care. "The RPD designation ... previously granted by the FDA in this indication," said ...
Breaking Medicine Technology: